Results 171 to 180 of about 16,216 (335)

The Optimisation of Carrier Selection in Dry Powder Inhaler Formulation and the Role of Surface Energetics. [PDF]

Biomedicines, 2022
Abiona O, Wyatt D, Koner J, Mohammed A.
europepmc   +1 more source

Decarbonising Respiratory Care: The Impact of a Low‐Carbon Salbutamol Pressurised Metered‐Dose Inhalers

Allergy, EarlyView.
Healthcare systems contribute up to 5% of global GHG emissions, with inhalers contributing a proportion of these. The carbon footprint of current salbutamol inhalers (pMDI with HFA‐134a propellant and DPI) and a planned salbutamol pMDI with low‐GWP propellant HFA‐152a was quantified across seven countries.
James King, Ashley Woodcock, Antonio Anzueto, Alexander J. K. Wilkinson, Christer Janson, Richard Henderson, Sourabh Fulmali, Maximilian Plank   +7 more
wiley   +1 more source

Future of Carrier-Free Dry Powder Inhaler Formulations [PDF]

Pharmaceutical Sciences
Ali Nokhodchi, Taravat Ghafourian
doaj   +1 more source

Ease-of-use preference for the ELLIPTA® dry powder inhaler over a commonly used single-dose capsule dry powder inhaler by inhalation device-naïve Japanese volunteers aged 40 years or older

International Journal of COPD, 2014
Yuko Komase,1 Akimoto Asako,2 Akihiro Kobayashi,3 Raj Sharma4 1Department of Respiratory Internal Medicine, St Marianna University School of Medicine, Yokohama City Seibu Hospital, Yokohama, Kanagawa, Japan; 2MA Respiratory Department, Development and ...
Komase Y, Asako A, Kobayashi A, Sharma R
doaj  

Advancement of a high-dose infant air-jet dry powder inhaler (DPI) with passive cyclic loading: Performance tuning for different formulations. [PDF]

Int J Pharm, 2023
Howe C, Momin MAM, Aladwani G, Strickler S, Hindle M, Longest W.   +5 more
europepmc   +1 more source

Asthma patient satisfaction with different dry powder inhalers [PDF]

, 2019
Antonio Valero, Paula Ribó, Luís Máiz, Esther Barbero, Myriam Calle Rubio, Carlos Campo, Paula Rytilä, Jordi Giner, Vicente Plaza   +8 more
openalex   +1 more source

78 Comparison of pierced versus broken capsules on delivered fine particle dose for the colistimethate dry powder inhaler

, 2014
May Ng, A. Kassamali, C. Scott
openalex   +1 more source

Pharmacological inhibition of hydroxysteroid 11‐beta dehydrogenase type 1 (11‐βHSD1) after myocardial infarction preserves cardiac function in a translational mini‐pig model

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Plasma glucocorticoids increase acutely after MI, thereafter tissue levels are amplified selectively within cells expressing 11‐ßhydroxysteroid dehydrogenase type 1 (11‐ßHSD1) that regenerates active glucocorticoids from circulating metabolites.
Sara Al Disi, Raimondo Ascione, Shazia Khan, Thomas Johnson, Eva Sammut, Vito Domenico Bruno, Daniel Baz Lopez, Carol‐Anne James, Joanna Simpson, Natalie Z. Homer, Michael Millar, Trisha Singh, Alex von Kreigsheim, Nick L. Mills, Brian R. Walker, Ruth Andrew, Scott P. Webster, Andrew Whittaker, Adrian Freeman, Gillian A. Gray   +19 more
wiley   +1 more source

Allyl isothiocyanate dry powder inhaler based on cyclodextrin-metal organic frameworks for pulmonary delivery. [PDF]

iScience, 2023
Sun N, Zhang M, Zhu W, Song P, Dai T, Huang P, Han Z, Wang D.   +7 more
europepmc   +1 more source

An Open-Label, Single-Arm, Multicentric, Prospective, Phase IV Study to Evaluate the Safety and Effectiveness of Indacaterol/Mometasone/Glycopyrronium Dry Powder Inhaler (DPI) in the Management of Asthma Patients (OASIS Study) [PDF]

Saurabh Karmakar, Suresh G Bhate, Vijaykumar Bhagwan Barge, Vinod Kumar, Anjali Nath, Ekta Sinha, Sagar Bhagat, Saiprasad Patil, Sumit Bhushan, Rujuta Gadkari, Hanmant Barkate   +10 more
openalex   +1 more source